LoginSubscribe Now
International In-house Counsel Journal Logo
International In-house Counsel Journal Logo
  • Home
  • Business Sectors
  • Areas of Law
  • Editorial Board
  • Write a Paper
  • Subscribe
  • Books
  • Reports
  • Back Issues
  • Terms and Conditions
  • Cookie Policy
  • Privacy Policy
  • PLS LogoCopyright & permissions
© 2026 International In-house Counsel Journal Ltd. | ISSN 1754-0607 | Picture Credits: Freepix, Unsplash and by permission of the authors
Back to library search

Here We Go Again: Has the European Court of Justice revived the cross-border patent injunction?

December 2012Intellectual PropertyHealthcare

Abstract

After a brief period of inactivity, the European Court of Justice has revisited the subject of pan-European cross-border injunctions. In Solvay SA v. Honeywell Fluorine Products Europe BV and Others, the ECJ was asked to elaborate on the requirements for granting such injunctions in proceedings on the merits, and to examine whether it is permissible to grant these injunctions in provisional proceedings. After the Advocate General issued an advisory opinion in this matter, the ECJ has now seemingly again opened the door to the possibility of granting such injunctions. After briefly outlining the history cross-border injunctions, this article will examine the requirements for their granting. Then, the Advocate General’s guidance will be considered, and practical suggestions concerning Solvay will be offered. These suggestions will take into account both the law surrounding cross-border injunctions, and broader considerations surrounding patent harmonization in Europe.

Subscribe to reador
PLS Logo Copyright & permissions

Author

Paul Coletti

Associate Patent Counsel, Johnson & Johnson, USA

Related Papers

REMS Patents: Listability and Other Issues
Abstract: Are Risk Evaluation and Mitigation Strategy (REMS) patents Orange Book listable (or even should be)? A straightforward question with a lot of disagreement. This paper discusses recent litigation on...Read more
Portrait image of Joanna Brougher
Joanna Brougher
Owner & Principal, BioPharma Law Group PLLC, USA
Portrait image of Tom Irving
Tom Irving
Partner, Marbury Law Group, USA
Portrait image of Stacy Lewis
Stacy Lewis
Law Clerk, Finnegan, USA
Portrait image of Mark Feldstein
Mark Feldstein
Partner, Finnegan, USA
Portrait image of Adriana Burgy
Adriana Burgy
Finnegan, USA
Creative Claiming Strategies
Innovator companies in the biopharmaceutical space are looking to their patent counsel for creative patent claiming strategies to protect their assets. In this article, using the Federal Circuit opinions in...Read more
Portrait image of Angela Sebor
Angela Sebor
Director Intellectual Property, Tolmar, Inc., USA
Portrait image of Xiaoguang Michelle Gao
Xiaoguang Michelle Gao
Associate VP - Assistant General Patent Counsel, Eli Lilly and Company, USA
Portrait image of Stacy Lewis
Stacy Lewis
Law Clerk, Finnegan, USA
Benefits of a Global Mindset to the Administrative Backbone of an Intellectual Property Department
The backbone of a well-functioning Intellectual Property department is made up of three major elements: the people, the systems and the processes that connect those people and systems. This paper...Read more
Portrait image of Maja Schmitt
Maja Schmitt
Head of Global Administration, Dsm, Netherlands
Innovative Programs in Technology Transfer: An Overview of Cedars-Sinai’s Technology Transfer International Program and Its Complementary Diagnostic Development Unit, 3rd Street Diagnostics
Technology transfer offices at nonprofit academic medical centers face many challenges in their mission to protect and commercialize the intellectual property developed at their institutions. To address these challenges and...Read more
Portrait image of Alexander Chai
Alexander Chai
Assistant Legal Counsel, Cedars-Sinai Medical Center, USA
Portrait image of Nirdesh Gupta Ph.D.
Nirdesh Gupta Ph.D.
Director of IP Portfolio Management & Licensing, Cedars-Sinai Medical Center, USA
Portrait image of James Lau
James Lau
Singapore